Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients

2013161 citationsJournal Article

Authors

Takao Koike · NTT Medical Center

Masayoshi Harigai · Tokyo Medical and Dental University

Naoki Ishiguro · Nagoya University

Shigeko Inokuma · Japanese Red Cross Medical Center

Syuji Takei · Kagoshima University

Tsutomu Takeuchi · Keio University

Hisashi Yamanaka ·

Abstract

Adalimumab, especially with concomitant use of MTX, provided significant improvement in disease activity, without any unexpected ADRs in Japanese RA patients.

Topics & Keywords

Rheumatoid Arthritis Research and Therapies Autoimmune and Inflammatory Disorders Research Chronic Lymphocytic Leukemia Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Modern Rheumatology

Volume 24, Issue 3, pp. 390-398

DOI: 10.3109/14397595.2013.843760

Field-Weighted Citation Impact: 13.56